logo
How ‘longevity' became the new buzzword in health

How ‘longevity' became the new buzzword in health

Business Times30-05-2025
AT A time when many of us might feel powerless to influence world events, perhaps it's not surprising that our society is trying ever harder to exercise the ultimate form of personal control: over our own mortality. The desire for a long – even eternal – life is nothing new (China's first emperor and creator of the Terracotta Army, Qin Shi Huang, ordered subjects to search for the elixir of everlasting life). Now, however, this impulse is coalescing around one particular buzzword: longevity.
It's a timely topic, given that between 2015 and 2050, the proportion of the world's population over 60 years will nearly double from 12 per cent to 22 per cent, according to the World Health Organization. But beyond its most basic definition, the word 'longevity' has acquired myriad new associations. Now, established ways to improve your chances of living longer – such as giving up smoking, exercising more, not getting lonely – aren't as attention-grabbing as commercialised, often competitive, approaches to extending your life.
Many approaches are constructive, such as that of Andrew J Scott, professor of economics at London Business School and author of The Longevity Imperative, who focuses on 'healthy longevity', and posits that there are other markers of ageing beyond chronological age.
But increasingly, the term is cropping up in marketing speak and in the luxury and lifestyle worlds. We now have hotels such as the Longevity Health and Wellness Hotel in the Algarve; a Longevity Lounge at wellness clinic Cloud Twelve in London, with biohacking gadgets such as a space-age-looking red light therapy helmet designed to promote hair growth and reduce brain fog. And then there's the Corinthia hotel's partnership with the London Regenerative Institute, offering everything from epigenetic testing aimed at determining how fast you are ageing, to hyperbaric oxygen therapy.
Dior's L'Or de Vie La Creme (£1,400, or S$2,400, for 50ml) contains 'Golden Drop Life Technology', a 'longevity elixir'; while this month, Swiss 'longevity brand' Loya launched moisturisers and serums that it says will bring 'a completely new category of wellness to the UK market'. Apparently, 'proprietary HappyFeelBoost technology' will rejuvenate skin and lift your mood. Any resemblance to the 'hypnopaedic' slogans in Aldous Huxley's Brave New World is purely coincidental.
This year, Alex Hawkins, director of strategic foresight at The Future Laboratory, co-authored a report produced by The Future Laboratory in partnership with Together Group, about how luxury is embracing longevity.
A NEWSLETTER FOR YOU
Friday, 2 pm Lifestyle
Our picks of the latest dining, travel and leisure options to treat yourself.
Sign Up
Sign Up
Hawkins tells me that a key character in taking the concept mainstream is super-rich biohacker Bryan Johnson, the subject of the Netflix documentary Don't Die: The Man Who Wants to Live Forever, and whose bid to reverse ageing has involved futuristic and dystopian strategies such as receiving blood transfusions from his teenage son.
Then there's the research around Blue Zones – global communities with a high concentration of people living to an advanced age, the subject of another Netflix documentary released in 2023.
Biohacker Bryan Johnson's bid to reverse ageing has involved futuristic and dystopian strategies such as receiving blood transfusions from his teenage son. PHOTO: BLOOMBERG
Hawkins says: 'Those two things open up an interesting split in the longevity conversation. On the one hand you have this high-tech, science-driven approach where someone is actively throwing quite a lot of money and technology at understanding and optimising their own ageing process; and on the other, with the Blue Zones, it's a radically back-to-basics approach to health. A lot of the reasons that we see people living longer in Blue Zones are really foundational things, like having strong community ties and eating relatively unprocessed diets.'
However, Johnson's Rejuvenation Olympics – a competition that encourages participants to measure their 'biological age' and upload it to a public leaderboard – demonstrates a competitive element to longevity pursuits. They have become a fitness flex, just like posting Insta pictures of yourself doing burpees as part of a Hyrox race. Where once people would brag about being 'crazy busy' or pulling an all-nighter at work, now, logging eight hours of sleep on your Oura ring score carries more cachet. There's been such a culture shift that it seems extraordinary now that live fast, die young was ever considered a cool rock'n'roll mantra.
Hawkins says the Future Laboratory report was exploring 'this idea that you and your quality of life are ultimately your greatest investment. It's definitely a status symbol in that way. Perhaps in the future it won't be so much about the designer handbag, it's more what treatments you have access to, what means you have to take control over your ageing.'
As consumers prioritise experiences over products, high-end fashion and beauty brands are following suit, aiming to offer what The Future Laboratory calls 'a new paradigm of transformational luxury'. Often, that might seem as much about looking younger for longer, as much as the prospect of actually living longer.
Not that it's limited to the highest end of the market. According to McKinsey's latest 2025 Future of Wellness Report, up to 60 per cent of consumers report that healthy ageing is a 'top' or 'very important' priority'. It notes that 'products and services have emerged to address these needs, including skincare products targeting long-term skin health and wrinkle prevention, supplements that claim to slow cellular ageing, epigenetic age-testing kits, virtual physical therapy solutions, and more'.
But is the word longevity really set to stay in the conversation? Or like the increasingly woolly 'wellness', will its meaning be diluted until it's used to describe random products in the outer reaches of Amazon? Anyone for a pair of marshmallow-pink-coloured Warmies, described as heatable wellness boots, scented with French lavender?
In other words, does longevity have longevity?
Anna Pione, a partner at McKinsey in New York, says: 'Where I think there is risk of a fad is in specific applications of what longevity means. Right now, like wellness, it's an extremely broad term... Do I think it will have the same prevalence in marketing language a few years from now? That's open for debate. It depends on whether some of these products and services really take hold and if consumers continue to see the value, as to whether you might see more of it.'
While longevity is predicted to be a growth area in hospitality, plenty of the major players seem measured in their use of the tag. Perhaps wanting to tap into its zeitgeisty vibes without overcommitting, should it become supplanted by another new term. The Soho Health Club, part of the Soho House Group, states on its website that facilities are 'designed to encourage performance and promote holistic wellness and longevity', via treatments such as contrast therapy (ice baths, infrared sauna) and IV drips including NAD+ (nicotinamide adenine dinucleotide, a molecule favoured by various celebrities for anti-ageing).
However, Thiago Alves, Soho Health Club's UK manager, says: 'I don't necessarily have any member coming to me asking for longevity treatments. I think members are more curious about health optimisation, they want to live longer, they want to live better. They want to have a good time with us... we use quite a few words, but we don't necessarily use the word longevity so explicitly.'
The Dorchester Collection has revamped its spa at Coworth Park. Teresa O'Farrell, its global head of wellness and spa, who was part of the process, is also measured in her approach to namechecking longevity. 'It is something we talk about but we're not using it as a buzzword.' In fact she still talks about 'wellness' because it's 'the journey to longevity'.
'There are lots of extreme therapies, but Coworth Park is a countryside estate and we know that being in nature is good for physical and mental wellness, so that is part of longevity,' she says. 'You hear the birds, smell the fresh air the, trees, the grass, the flowers. As people walk up the path to the spa they are already reducing their stress.'
McKinsey's Anna Pione also emphasises that consumers will need to feel short-term benefits from products that promote longevity. Not everyone wants to wait half a century or more to find out if those supplements do what they say on the tin. FINANCIAL TIMES
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Gilead, Global Fund finalize plan to supply HIV prevention drug to poor countries
Gilead, Global Fund finalize plan to supply HIV prevention drug to poor countries

Straits Times

time09-07-2025

  • Straits Times

Gilead, Global Fund finalize plan to supply HIV prevention drug to poor countries

Sign up now: Get ST's newsletters delivered to your inbox Gilead Sciences and the Global Fund to Fight AIDS, Tuberculosis and Malaria said on Wednesday they had finalized plans to supply a long-acting HIV prevention drug to low-income countries, despite the absence of funding from a key U.S. initiative aimed at addressing the global HIV/AIDS epidemic. Under the agreement, Gilead said it will supply, at cost, enough doses to reach up to 2 million people over three years in countries supported by the Global Fund. Both parties said price terms are confidential, and the Global Fund declined to comment further on how many doses would be ordered immediately. The U.S. Food and Drug Administration last month approved Gilead's lenacapavir, a twice-yearly injection, for preventing HIV infection in adults and adolescents. The World Health Organization and other regulators are currently reviewing it. Last year, Gilead signed royalty-free deals allowing six generic drugmakers to make and sell low-cost versions of the drug in 120 low- and middle-income countries, but those supplies will take time to get up and running. Some AIDS experts have said the new drug could help end the 44-year-old epidemic that infects 1.3 million people a year and is estimated by the World Health Organization to have killed more than 42 million. The Global Fund said it will prioritize access based on HIV incidence and prevention strategies, including countries in sub-Saharan Africa that have expressed strong interest - notably South Africa, which will be among the first to roll out the drug among around 10 other nations. The partners aim to have the first delivery reach at least one African country by the end of this year. Top stories Swipe. Select. Stay informed. Singapore Singapore to hire more than 1,000 new educators annually in the next few years, up from 700 Singapore COE prices rise for all categories Asia Malaysia confirms existence of document central to ex-PM Najib's house arrest bid, say reports Singapore Man who killed cats by throwing them off HDB blocks has jail term doubled to 27 months Singapore $43k fine for undischarged bankrupt doctor who failed to disclose assets worth over $4m Singapore Female primary school teacher charged over alleged sex acts with underage male student Singapore Goodbye fraudsters? Dating app Coffee Meets Bagel rolls out identity verification Asia Amid handshakes and familiar friends, Asean navigates tariffs and tension in KL "For the first time, a tool to prevent HIV infection is coming available in low and middle-income countries at the same time as in high-income countries," Peter Sands, executive director of the Global Fund, said in an interview with Reuters. In the past, this has taken years, he added. Gilead, the Global Fund and the United States President's Emergency Plan for AIDS Relief had announced the plan in December. However, the administration of U.S. President Donald Trump, who took office in January, has pulled back on PEPFAR funding, limiting global HIV prevention programs to pregnant and breastfeeding women. In response to questions about the impact of the cuts on HIV programs worldwide, a U.S. State Department spokesperson told Reuters: "PEPFAR-funded programs that deliver HIV care and treatment or prevention of mother-to-child transmission services are operational... All other PEPFAR-funded services are currently being reviewed." They did not respond to questions on lenacapavir specifically. Gilead CEO Daniel O'Day said he is still hopeful that U.S. aid spending to fight the epidemic will resume. "We want to be spending less over time on HIV because the incidence is lower ... we should put resources toward things that actually reduce the burden of disease over time." Gilead is also working with middle-income countries, many of which are in Latin America, to make lenacapavir accessible as soon as possible, he said. The drug, which has the brand name Yeztugo, has an annual list price in the United States of $28,218. The Children's Investment Fund Foundation pledged $150 million to the Global Fund earlier this year, including money for the lenacapavir initiative. Sands said more donors were also needed. REUTERS

Measles-infected person visited Osaka Expo on June 21; visitors with symptoms urged to seek medical advice
Measles-infected person visited Osaka Expo on June 21; visitors with symptoms urged to seek medical advice

Asia News Network

time08-07-2025

  • Asia News Network

Measles-infected person visited Osaka Expo on June 21; visitors with symptoms urged to seek medical advice

July 8, 2025 TOKYO – A young resident of Kanagawa Prefecture visited the 2025 Osaka-Kansai Expo on the same day that he developed symptoms of the measles, the prefectural government said Saturday. Aged from 10 to 19, the person is a resident of Hiratsuka in the prefecture and went to the Expo on June 21, according to the prefectural government. The Kanagawa and Osaka prefectural governments are calling for anyone who visited the venue on the same day and developed a fever or other symptoms to contact a medical facility about possible treatment. The resident traveled to Osaka by car and took a shuttle bus from a parking lot in Sakai, Osaka Prefecture, from about 8 a.m. to 8:30 a.m. to the Expo venue, according to the Kanagawa prefectural government and others. He visited eight pavilions, including those for the European Union and Cambodia, from around 9 a.m. to 3 p.m. He then returned to the parking lot via shuttle bus from around 3 p.m. to 3:30 p.m. The young person had a fever and a headache on the day that he visited the Expo. As he also developed a rash, he visited a medical institution on June 25 and 27. Genetic testing by the Kanagawa Prefectural Institute of Public Health confirmed Thursday that he had contracted measles. He has no history of overseas travel and how he became infected is unknown, according to the prefectural government. As of June 29, a total of 32 people had been confirmed to have contracted measles in Kanagawa Prefecture this year, the institute said. Highly contagious airborne disease Measles is highly contagious and spreads through the air. It can be transmitted through droplets from coughing or sneezing, as well as by direct contact with an infected person. When the virus enters the body of a person who is not immune, symptoms such as a fever, cough and rash appear within 10 to 12 days in most cases. Measles can cause pneumonia and encephalitis and is said to be fatal in 1 in 1,000 cases. Just washing one's hands and wearing a mask cannot fully prevent infection. Receiving two doses of vaccine is considered effective. The World Health Organization verified that Japan had eliminated endemic measles transmission in 2015, but new cases have continued to be confirmed. According to the Japan Institute for Health Security, 156 cases of infection had been confirmed nationwide this year as of June 22. The Expo visitor who tested positive had received two doses of vaccine. 'People who have been vaccinated twice will excrete fewer viruses. If you experience symptoms such as fever or rash, please consult a medical institution before seeking treatment,' said Atsuo Hamada, a specially appointed professor at Tokyo Medical University and an expert on travel medicine.

Eye care giant Alcon keeps 'lens' on the future with expanded manufacturing and logistics facility in Tuas, Singapore News
Eye care giant Alcon keeps 'lens' on the future with expanded manufacturing and logistics facility in Tuas, Singapore News

AsiaOne

time28-06-2025

  • AsiaOne

Eye care giant Alcon keeps 'lens' on the future with expanded manufacturing and logistics facility in Tuas, Singapore News

Eye care-device giant Alcon officially opened its expanded state-of-the art manufacturing and logistics facility in Tuas Biomedical Park on Friday (June 27) morning. This brings Alcon's investments in Singapore to more than US$600 million (S$765 million) since it began operations in Singapore back in 2005. The completed Tuas facility is one of the Swiss-American firm's largest high-tech manufacturing sites with Industry 4.0 capabilities, advanced automation and smart manufacturing systems to meet the increasing global demand for its contact lenses. Amid a growing middle class and rising demand for quality healthcare, the Asia-Pacific region continues to be the fastest-growing market for medical technology, with its market value projected to reach nearly S$300 billion by 2030. This puts the region second only to the US as a source of demand for medical technology (Medtech). "Singapore is home to some of the world's best-in-class Medtech manufacturing palnts. The sector has been growing steadily, with a manufacturing output of S$19.4 billion in 2023. This marks a $5.2 billion increase over the past decade," said Senior Minister of State for Trade and Industry Low Yen Ling at the opening ceremony of Alcon's expanded facility. Beyond strengthening innovation and supply chain resilience within Singapore's MedTech ecosystem, Alcon's investment is also expected to benefit Singaporean workers and small- and medium-sized enterprises (SMEs) in Singapore. Muhammad Haiqal Bin Sapuan, an associate supervisor at Alcon made the switch from the oil and gas industry, through the Career Conversion Programme (CCP), in 2022 to have more time with his family. A year and a half into his role as a senior technician, he was nominated by his peers to step up as an associate supervisor. [[nid:707984]] "That recognition gave me confidence. I started off as an interim, and it was tough at first, but the team's support made the difference," said Haiqal. To date, nearly 180 Singaporean workers have benefitted from the CCP to become Alcon associates. Alcon's new facility is expected to create new job opportunities in production operations, quality control and supply chain management. It is also expected to strengthen innovation and supply chain resilience within Singapore's Medtech ecosystem through initiatives such as the Partnership for Capability Transformation, which partners local SMEs to buiild capabilities from precision moulding to packaging, helping them to scale and compete globally. [[nid:715407]] editor@

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store